HBOT Conversations:
Join us for interviews with researchers, practitioners, industry experts, and patients to share their stories, successes, and expertise relative to hyperbaric oxygen therapy
Subscribe. Join the discussion. Share the hope.
Listen to or Watch the HBOT Conversations Podcast
Listen to the HBOT Converstations podcast by downloading it from your favorite podcasting platform or scroll down and watch an episode here on the HBOT News website:
Watch the HBOT Conversations Podcast
Subscribe Now, It’s Free !
Recent HBOT News
Hyperbaric oxygen in chronic traumatic brain injury: oxygen, pressure, and gene therapy.
Abstract: Hyperbaric oxygen therapy is a treatment for wounds in any location and of any duration that has been misunderstood for 353 years. Since 2008 it has been applied to the persistent post-concussion syndrome of mild traumatic brain injury by civilian and later...
Clinical Trial – Spinal Morphine Provides an Effective Pain Control in Patients Undergoing Transurethral Resection of Prostate Gland
Pain after transurethral resection of prostate is considered mild to moderate severity from
detrusor muscle spasm and traction from urinary catheter. Numerous pain relieve methods have
been studied including spinal opioids, spinal anesthesia with local anesthetic and
dexmedetomidine, periprostatic nerve blockade with bupivacaine and mixing of prilocaine with
distilled water irrigation while undergoing a procedure. Most of patients having this
procedure are in elderly period, thus many anesthetists avoided spinal morphine which may
cause respiratory depressant effect postoperatively. Although previous studies showed
effectiveness of spinal morphine 25-200 mcg, some patients suffered from neuraxial opioid
side effects.
The aim of this study is to demonstrate efficacy of local anesthetic with intrathecal
morphine 50 mcg providing pain relieve after transurethral resection of prostate compare to
spinal anesthesia with sole local anesthetic.
Clinical Trial – Hyperbaric Oxygen Therapy Registry
The purpose of the Hyperbaric Oxygen Therapy Registry (HBOTR) is to provide real world
patient outcome and side effect information from electronic health records submitted to a
specialty specific hyperbaric registry as part of "Stage 2 of Meaningful Use," including data
provided to meet PQRS requirements via the registry’s QCDR mission.
Goals include understanding the value of HBOT among patients treated for a variety of
conditions in relation to the frequency and severity of HBOT side effects. While randomized,
controlled trials can establish the efficacy of treatments like HBOT, because they routinely
exclude patients with co-morbid conditions common to those patients seen in usual clinical
practice, the results of RCTs are usually non-generalizable. Real world data can be used to
better understand the effectiveness of HBOT among typical patients, as well as the risks
associated with treatment.